Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive: Acorda Therapeutics Inc
Enter Symbol or Keywords
x
Acorda Therapeutics' Cash Flow from Operations Turns Positive for its Twelve Months   Stock Quote: (NasdaqNM:ACOR)
11/11/2009  
25.97 -0.47 -1.78% 160,233
Acorda Therapeutics' Cash Flow from Operations Turns Positive for its Twelve Months  
Last Price Change % Chg Volume
New York, NY, November 11, 2009-CFFO-NEWS reports that Cash Flow from Operations (CFFO) for Acorda Therapeutics, Inc. (NASDAQ:ACOR) for its twelve months ended September 30, 2009 was a positive $34,55 ... read full story  
Website Address: www.acorda.com
Industry: Bio-Pharma & Therapeutics
Most Recent STN Exclusives
x
11/04/2010
Cash Flow from Operations for SAP AG Reaches Nine Year High
11/04/2010
Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com
11/04/2010
Cash Flow from Operations for Pepco Holdings Reaches Four Year High
11/04/2010
Cash Flow from Operations Increases 151% for KLA-Tencor
11/04/2010
Seven Year High in Cash Flow from Operations for Dana Holding
11/04/2010
Public Service Enterprise's Cash Flow from Operations Increases 48%
11/04/2010
StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"
11/04/2010
Free Cash Flow Turns Negative for Goodyear's Third Quarter
11/04/2010
Cash Flow from Operations for Waste Management Increases 17.7%
11/04/2010
Free Cash Flow for America Movil Reaches Three Year High
Interactive Chart: ACOR
x
More STN Exclusives for: ACOR
x
08/18/2010
Three Year High in EBITDA for Acorda Therapeutics
08/17/2010
Acorda Therapeutics Experiencing Revenue Uptrend While its Industry is in a Downtrend
08/16/2010
OPS Ranking of "4" Reiteration for Acorda Therapeutics
... more ACOR exclusives
Other News Sources: ACOR
x
02/07/2012
Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference
02/06/2012
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES(R)
02/03/2012
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke
... more ACOR news from other sources
Daily Market Updates
x
02/08/2012
Markets Open Mixed and Move Up Slightly in Early Trading
U.S. markets are up modestly in early trading as investors hope that a Greek austerity deal will be coming soon in order to avoid a chaotic default. The European Central Bank has made key concessions regarding its holdings of Greek government bonds, ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2012 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us